The age-specific cervical cancer incidence in Denmark is bimodal with peaks at ages 35-40 years and 75 years. Yet, Danish women ≥ 65 years are not offered screening for cervical cancer. Screening women beyond the age of 65 years may reduce cervical cancer incidence as well as mortality, and seems to be cost-effective. Older women may benefit more from human papillomavirus screening rather than by cytology. Thus, more research on cervical cancer screening in older women is warranted.